Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine/Atorvastatin in Knee Osteoarthritis
NCT01645176Phase 2Completed
- Sponsor
- Stanford University
- Start
- May 2012
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydroxychloroquine, atorvastatin in knee osteoarthritis (OA), sponsored by Stanford University. Started May 2012; status: completed.
02
Drugs
hydroxychloroquineatorvastatin
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01645176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01645176.